Axela Bio, a CRO specializing in discovery biology and Translational Sciences.
Axela Bio, a CRO specializing in discovery biology and Translational Sciences.
B lymphocytes are an essential component of the humoral immune response. Produced in the bone marrow, B cells migrate to the spleen and secondary lymphoid tissues where they mature and differentiate into immunocompetent B cells. A part of the adaptive immune system, B cells are responsible for generating antibodies to specific antigens, which then bind via B cell receptors.
B cell activation, like T cell activation, also requires two signals. The first signal is provided by the B Cell Receptor (BCR), a surface-expressed antibody binding to its cognate antigen. This signal may also be mimicked using anti-IgM or IgD antibodies. The second signal is achieved through engagement of co-stimulatory molecules such as CD40 and cytokine signaling. Alternatively, components of bacterial cell walls, such as Lipopolysaccharide (LPS), and antigens with highly repetitious molecules may signal B cell activation directly.



NanoBiotec & PicoImmune
joined Axela Biosciences, Inc. in 2024!
We've moved to a new campus, "the birthplace of Interferon" !